>_ QFI Terminal
Terminal › Stocks › ALGN

Align Technology, Inc. (ALGN) Stock

Healthcare · Medical - Devices · US
$172.08 -1.25%
Last updated Nov 12, 2026 09:31 UTC

ALGN Key Statistics

Market Cap$12.22B
P/E (TTM)25.04
P/S (TTM)2.94
P/B (TTM)2.84
Revenue (TTM)$4.16B
EPS (TTM)$6.87
Dividend Yield—
ROE (TTM)11.76%
Net Margin11.83%
Gross Margin69.14%
52W High$200.44
52W Low$130.23
Analyst ViewBuy
Price Target$190.00
Employees20,290
Volume860,583

About Align Technology, Inc.

Align Technology, Inc. is a medical technology enterprise that develops, produces, and markets its leading products: Invisalign transparent dental aligners and iTero digital intraoral scanners, along with related services. These offerings serve a wide range of dental professionals, including orthodontists, general dentists, and those specializing in restorative and cosmetic dentistry. The company's operations are divided into two main business units: "Clear Aligner" and "Scanners and Services." The Clear Aligner segment offers a variety of solutions. Its comprehensive products include the full Invisalign treatment for teenage patients, designed to address complex orthodontic needs such as mandibular advancement, patient compliance tracking, and managing tooth eruption. It also features specialized Invisalign First Phase I and Phase 2 packages for younger children, typically aged seven to ten, who have mixed dentition (a combination of primary and permanent teeth). Beyond these, the segment provides non-comprehensive aligner options like Invisalign moderate, lite, express, and Invisalign Go. Additional non-case products include retention devices, fees for Invisalign training, and sales of ancillary items such as cleaning materials and adjustment tools used by dental practitioners during treatment. The Scanners and Services segment centers around the iTero scanner, a unified hardware platform offering various software applications for both restorative and orthodontic procedures. It supplies specialized restorative software to general dentists, prosthodontists, periodontists, and oral surgeons, as well as distinct software for orthodontists to manage digital patient records, perform diagnoses, and facilitate the fabrication of printed models and retainers. This segment also provides computer-aided design and manufacturing (CAD/CAM) services, along with supplementary products like disposable covers for the scanner wand and iTero models and dies. Furthermore, it includes third-party scanners and digital scan solutions, the Invisalign Outcome Simulator (a chair-side and cloud-based application for the iTero scanner), the Invisalign Progress Assessment tool, and TimeLapse technology, which enables clinicians to compare a patient's historical 3D scans against current data. Align Technology distributes its products worldwide, with a strong presence in the United States, Switzerland, and China. Founded in 1997, the company is headquartered in Tempe, Arizona.

CEO: Joseph Hogan. Company website

ALGN — Frequently Asked Questions

What is the ALGN stock price today?

Align Technology, Inc. (ALGN) trades at $172.08, down 1.25% on the day, as of Nov 12, 2026 09:31 UTC.

What is Align Technology, Inc.'s market cap?

Align Technology, Inc. has a market capitalisation of $12.22B, calculated from the live ALGN share price and shares outstanding.

What is the P/E ratio of ALGN?

ALGN trades at a trailing P/E of 25.04, from earnings per share of $6.87 over the last twelve months.

How much revenue does Align Technology, Inc. make?

Align Technology, Inc. generated revenue of $4.16B over the trailing twelve months, which puts the stock at 2.94 times sales.

What is the 52-week range for ALGN?

ALGN has traded between $130.23 and $200.44 over the past 52 weeks, and the last price is 14.1% below that high.

Is Align Technology, Inc. profitable?

Yes. Align Technology, Inc. keeps 11.83% of revenue as net income over the trailing twelve months.

What is the analyst price target for ALGN?

Wall Street analysts rate ALGN Buy, with an average price target of $190.00, 10.4% above the current price.

What sector is Align Technology, Inc. in?

Align Technology, Inc. is classified under the Healthcare sector and the Medical - Devices industry, and is domiciled in US.

Who is the CEO of Align Technology, Inc.?

Joseph Hogan is the chief executive of Align Technology, Inc., which employs 20,290 people.

Where can I track ALGN in real time?

QFI Terminal shows ALGN with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.

See ALGN live in QFI Terminal

Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.

Open ALGN in Terminal See plans

Medical - Devices stocks

ABT Abbott Laboratories MDT Medtronic Plc SYK Stryker Corporation GEHC GE HealthCare Technologies Inc. BSX Boston Scientific Corporation ZBH Zimmer Biomet Holdings, Inc. EW Edwards Lifesciences Corporation SNN Smith & Nephew plc DXCM DexCom, Inc. BRKR Bruker Corporation PODD Insulet Corp. GMED Globus Medical, Inc. BIO Bio-Rad Laboratories, Inc. ITGR Integer Holdings Corporation IART Integra LifeSciences Holdings Corporation PEN Penumbra, Inc. HAE Haemonetics Corporation TNDM Tandem Diabetes Care, Inc. NEOG Neogen Corporation TMDX TransMedics Group, Inc. AVNS Avanos Medical, Inc. GKOS Glaukos Corporation INMD InMode Ltd. PRCT PROCEPT BioRobotics Corporation

More Healthcare stocks

UNH UnitedHealth Group Incorporated CVS CVS Health Corp. MCK McKesson Corporation COR Cencora, Inc. NVO Novo Nordisk A/S CI Cigna Corporation CAH Cardinal Health, Inc. CNC Centene Corp. ELV Elevance Health Inc. HUM Humana Inc. JNJ Johnson & Johnson LLY Eli Lilly and Company HCA HCA Healthcare, Inc. MRK Merck & Co., Inc. ABBV AbbVie Inc. PFE Pfizer Inc.

ETFs holding ALGN

SPHB Invesco S&P 500 High Beta ETF 0.84% RSP Invesco S&P 500 Equal Weight ETF 0.21% XLV State Street Health Care Select Sector SPDR ETF 0.17% SCHV Schwab U.S. Large-Cap Value ETF 0.04% FNDX Schwab Fundamental U.S. Large Company ETF 0.03% IWD iShares Russell 1000 Value ETF 0.03% SPY State Street SPDR S&P 500 ETF 0.02% IVV iShares Core S&P 500 ETF 0.02% FB ProShares S&P 500 Dynamic Buffer ETF 0.02% SCHX Schwab U.S. Large-Cap ETF 0.02% IWB iShares Russell 1000 ETF 0.02% SCHB Schwab U.S. Broad Market ETF 0.02% VOO Vanguard S&P 500 ETF 0.01% VTI Vanguard Morningstar Total Stock Market ETF 0.01% UPRO ProShares - UltraPro S&P500 0.01% VT Vanguard Total World Stock ETF 0.01% SPXL Direxion Daily S&P 500 Bull 3X Shares 0.00%

Largest institutional holders of ALGN

FMR LLC 5,527,912 shares
BlackRock, Inc. BLK 4,419,366 shares
VANGUARD CAPITAL MANAGEMENT LLC 4,401,313 shares
Capital International Investors 4,045,561 shares
Capital World Investors 3,422,385 shares
GOLDMAN SACHS GROUP INC GS 3,372,760 shares
VANGUARD PORTFOLIO MANAGEMENT LLC 3,131,764 shares
STATE STREET CORP STT 2,558,512 shares
GEODE CAPITAL MANAGEMENT, LLC 2,315,071 shares
Ninety One UK Ltd 2,133,621 shares

ALGN insiders on other boards

NBIX Neurocrine Biosciences, Inc. Morrow George J ABT Abbott Laboratories Conroy Kevin T ILMN Illumina, Inc. Coletti Julie Ann LNG Cheniere Energy, Inc. Vitalone Britt J. MCK McKesson Corporation Vitalone Britt J. EXAS Exact Sciences Corporation Conroy Kevin T IART Integra LifeSciences Holdings Corporation Poul Mojdeh